Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling Study in patients with type 2 diabetes

Clinical Therapeutics

Volumn 30, Issue 12, 2008, Pages 2252-2262

  Reimer, Tanja ^a   Hohberg, Cloth ^a   Pfützner, Anke H ^a   Jørgensen, Christina ^b   Jensen, Klaus H ^b   Pfützner, Andreas ^a  

^a Institute for Clinical Research   (Germany)

^b NOVO NORDISK A S   (Denmark)

Author keywords

FlexPen ; handling test; HumaPen ; insulin pen; Luxura ; type 2 diabetes

Indexed keywords

INSULIN ASPART; INSULIN LISPRO; LUXURA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC PATIENT; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRAINING;

AGED; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEMS; DRUG PACKAGING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; TIME FACTORS;

EID: 58249129464     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.12.004     Document Type: Article

References (12)

1. Korytkowski M. When oral agents fail: Practical barriers to starting insulin. Int J Obes Relat Metab Disord. 26 Suppl 3 (2002) S18-S24
2. Korytkowski M., Bell D., Jacobsen C., Suwannasari R., and FlexPen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 25 (2003) 2836-2848
3. Keith K., Nicholson D., and Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila). 43 (2004) 69-74
4. Asakura T., Seino H., Kageyama M., and Yohkoh N. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin. 24 (2008) 1429-1434
5. Hänel H., Weise A., Sun W., et al. Differences in the dose accuracy of insulin pens. J Diabetes Sci Tech. 2 (2008) 478-481
6. Cefalu W.T., Mathieu C., Davidson J., et al., OPTIMIZE Coalition. Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: A multicenter follow-up study. Diabetes Technol Ther. 10 (2008) 25-38
7. Thurman J.E. Insulin pen injection devices for management of patients with type 2 diabetes: Considerations based on an endocrinologist's practical experience in the United States. Endocr Pract. 13 (2007) 672-678
8. Korytkowski M., Niskanen L., and Asakura T. FlexPen: Addressing issues of confidence and convenience in insulin delivery. Clin Ther. 27 Suppl B (2005) s89-s100
9. Pfützner A., Asakura T., Sommavilla B., and Lee W. Insulin delivery with FlexPen: Dose accuracy, patient preference and adherence. Expert Opin Drug Deliv. 5 (2008) 915-925
10. Niskanen L., Jensen L.E., Råstam J., et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther. 26 (2004) 531-540
11. Dreyer M. Comparison of metabolic control, safety, handling and patient acceptance of insulin delivery devices in patients with type 1 and type 2 diabetes. J Clin Res. 8 (2005) 1-7
12. Pfützner A., Reimer T., Hohberg C., et al. Prefilled insulin device with reduced injection force: Patient perception and accuracy. Curr Med Res Opin. 24 (2008) 2545-2549